SEC Form 4 · accession 0001140361-15-034888
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur H Amron
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 9, 2015 | A | 58,240 | $0.00 | A | 58,240 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On September 9, 2015, the Company granted 58,240 shares of restricted stock of the Company (the "Restricted Stock") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Stock Incentive Plan. At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.